阿拉丁跌2.00%，成交额6687.41万元，主力资金净流出1283.83万元

Core Viewpoint - Aladdin's stock has experienced fluctuations, with a recent decline of 2.00% and a year-to-date increase of 34.03%, indicating volatility in its market performance [1] Company Overview - Shanghai Aladdin Biochemical Technology Co., Ltd. was established on March 16, 2009, and went public on October 26, 2020. The company specializes in the research, production, and sales of reagents [1] - The company's revenue composition includes high-end chemicals (42.21%), life sciences (32.73%), analytical chromatography (13.78%), materials science (7.55%), laboratory consumables (2.01%), and others (1.72%) [1] Financial Performance - For the period from January to March 2025, Aladdin reported a revenue of 130 million yuan, representing a year-on-year growth of 32.20%, and a net profit attributable to shareholders of 24.18 million yuan, up 41.35% year-on-year [2] - Since its A-share listing, Aladdin has distributed a total of 241 million yuan in dividends, with 150 million yuan distributed over the past three years [3] Shareholder Information - As of March 31, 2025, Aladdin had 10,100 shareholders, an increase of 6.08% from the previous period, with an average of 27,331 circulating shares per shareholder, down 5.73% [2] - Notable institutional shareholders include China Europe Medical Health Mixed A, which increased its holdings by 3.37 million shares, and new entrants like China Europe Innovation Future Mixed [3]